Fludarabine for system suitability

Get a Price/Quote

MOQ : 1 Kilograms

Fludarabine for system suitability Specification

Usage
Fludarabine is FDA approved to treat people who have chronic lymphocytic leukemia (CLL) who have not responded to at least one standard alkylting-agent-containing regimen or whose disease has progressed during treatment with such a regimen.

Molecular Formula
C10H13FN5O7P

Purity
98%

Melting Point
(C), 260

Molecular Weight
365.212 Grams (g)

Fludarabine for system suitability Trade Information

Minimum Order Quantity
1 Kilograms

Payment Terms
Cash Advance (CA), Cash in Advance (CID)

Supply Ability
500 Kilograms KG Per Month

Delivery Time
2-8 Week

Sample Available
Yes

Sample Policy
Sample costs shipping and taxes has to be paid by the buyer

Packaging Details
Carton and Poly Bag.

Main Export Market(s)
Australia, Middle East, Central America, Africa, South America, Western Europe, Asia, Eastern Europe, North America

Main Domestic Market
All India

About Fludarabine for system suitability

Fludarabine for system suitabilitySynonym: 2-Fluoro-9-(5-O-phosphono--D-arabinofuranosyl)-9H-purin-6-amine, Fludarabine phosphate Empirical Formula (Hill Notation): C10H13FN5O7PMolecular Weight: 365.21CAS Number: 75607-67-9

FAQs of Fludarabine for system suitability:

Q: What is the molecular weight of Fludarabine?

A: The molecular weight of Fludarabine is 365.212 grams (g).

Q: What is the molecular formula of Fludarabine?

A: The molecular formula of Fludarabine is C10H13FN5O7P.

Q: What is the melting point of Fludarabine?

A: The melting point of Fludarabine is 260C.

Q: What is the purity specification of Fludarabine?

A: Fludarabine has a purity of 98%.

Q: What is the approved use of Fludarabine by the FDA?

A: Fludarabine is FDA approved to treat chronic lymphocytic leukemia (CLL) in individuals who have not responded to at least one standard alkylating-agent-containing regimen or whose disease has progressed during treatment with such a regimen.

Tell us about your requirement